{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:39:33Z","timestamp":1790879973507,"version":"4.1.0"},"reference-count":51,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH114967"],"award-info":[{"award-number":["R01MH114967"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To compare antidepressant utilization in individuals aged 5\u201319\u00a0years from the Scandinavian countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A population\u2010based drug utilization study using publicly available data of antidepressant use from Denmark, Norway, and Sweden.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the study period from 2007 to 2017, the proportion of antidepressant users increased markedly in Sweden (9.3\u201318.0\/1000) compared to Norway (5.1\u20137.6\/1000) and Denmark (9.3\u20137.5\/1000). In 2017, the cumulated defined daily doses (DDD) of selective serotonin reuptake inhibitors were 5611\/1000 inhabitants in Sweden, 2709\/1000 in Denmark, and 1848\/1000 in Norway. The use of \u2018other antidepressants' (ATC code N06AX) also increased in Sweden with a higher DDD in 2017 (497\/1000) compared to Denmark (225\/1000) and Norway (170\/1000). The use of tricyclic antidepressants was generally low in 2017 with DDDs ranging between 30\u201342 per 1000. The proportion of antidepressant users was highest among 15\u2010 to 19\u2010year\u2010old individuals. Girls were more likely to receive treatment than boys, and the treated female\/male ratios per 1000 were similar in Sweden (2.39), Denmark (2.44), and Norway (2.63).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Even in highly comparable healthcare systems like the Scandinavian countries', variation in antidepressant use is considerable. Swedish children and adolescents have a markedly higher and still increasing use of antidepressants compared to Danish and Norwegian peers.<\/jats:p><\/jats:sec>","DOI":"10.1111\/acps.13116","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T22:35:39Z","timestamp":1571265339000},"page":"34-42","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Trends in antidepressant use among children and adolescents: a Scandinavian drug utilization study"],"prefix":"10.1111","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-2739","authenticated-orcid":false,"given":"R.","family":"Wesselhoeft","sequence":"first","affiliation":[{"name":"Clinical Pharmacology and Pharmacy Department of Public Health University of Southern Denmark Odense Denmark"},{"name":"Research Unit of Child and Adolescent Mental Health Department of Clinical Research University of Southern Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. B.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Pharmacy Department of Public Health University of Southern Denmark Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Talati","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Division of Epidemiology Columbia University New York State Psychiatric Institute New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Reutfors","sequence":"additional","affiliation":[{"name":"Centre for Pharmacoepidemiology Department of Medicine Solna Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Furu","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases and Ageing and Centre for Fertility &amp; Health Norwegian Institute of Public Health Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Strandberg\u2010Larsen","sequence":"additional","affiliation":[{"name":"Section of Epidemiology Department of Public Health University of Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0591-7187","authenticated-orcid":false,"given":"P.","family":"Damkier","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry &amp; Pharmacology Odense University Hospital Odense Denmark"},{"name":"Department of Clinical Research University of Southern Denmark Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9314-5679","authenticated-orcid":false,"given":"A.","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Pharmacy Department of Public Health University of Southern Denmark Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bliddal","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Pharmacy Department of Public Health University of Southern Denmark Odense Denmark"},{"name":"OPEN \u2013 Open Patient data Explorative Network Department of Clinical Research University of Southern Odense Denmark"},{"name":"Odense University Hospital Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038248"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.150"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07030454"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.3.332"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp078015"},{"key":"e_1_2_11_7_1","unstructured":"EUROPEAN MEDICINES AGENCY.European Medicines Agency finalises review of antidepressants in children and adolescents. European Medicines Agency Press office London UK; 2005.https:\/\/www.ema.europa.eu\/en\/documents\/referral\/european-medicines-agency-finalises-review-antidepressants-children-adolescents_en.pdf. (Accessed August 7 2019)."},{"key":"e_1_2_11_8_1","first-page":"Cd002317","article-title":"Tricyclic drugs for depression in children and adolescents","author":"Hazell P","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.642864"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-4993(18)30138-X"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1687-7"},{"key":"e_1_2_11_12_1","first-page":"Cd006528","article-title":"Mirtazapine versus other antidepressive agents for depression","author":"Watanabe N","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20164806"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.2432"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.22329"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2018.01.015"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2016.02.001"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12155"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12633"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-018-01269-2"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-014-0523-1"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4138"},{"key":"e_1_2_11_23_1","first-page":"327","article-title":"Trends and patterns of antidepressant use in french children and adolescents from 2009 to 2016","volume":"2018","author":"Revet A","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10797-007-9022-3"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009460010196"},{"key":"e_1_2_11_26_1","unstructured":"WORLD HEALTH ORGANIZATION.Health for the world's adolescents: a second chance in the second decade: summary;2014."},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00494.x"},{"key":"e_1_2_11_28_1","unstructured":"WORLD HEALTH ORGANIZATION.Guidelines for ATC classification and DDD assignment 2019. WHO Collaborating Centre for Drug Statistics Methodology2018."},{"key":"e_1_2_11_29_1","volume-title":"A language and environment for statistical computing","author":"R Core Team","year":"2018"},{"key":"e_1_2_11_30_1","doi-asserted-by":"crossref","unstructured":"WickhamH.Easily Install and Load the'Tidyverse' R Package version 1.2.1;2017.","DOI":"10.32614\/CRAN.package.tidyverse"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g3596"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.6.884"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.46"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071265"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07010007"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142050-00002"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200204110-00005"},{"key":"e_1_2_11_38_1","first-page":"2s","article-title":"Pediatric migraine: recognition and treatment","volume":"105","author":"Hershey AD","year":"2005","journal-title":"J Am Osteopathic Assoc"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756285615616586"},{"key":"e_1_2_11_40_1","article-title":"Antidepressants for the treatment of abdominal pain\u2010related functional gastrointestinal disorders in children and adolescents","volume":"008013","author":"Kaminski A","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/1753-2000-5-28"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1999.tb07237.x"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/08039488.2017.1305445"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2010.06.009"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/08039488.2015.1061053"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-014-0553-8"},{"key":"e_1_2_11_47_1","unstructured":"Swedish National Board of Health and Welfare.Nationella riktlinjer f\u00f6r v\u00e5rd vid depression och \u00e5ngestsyndrom\u2013st\u00f6d f\u00f6r styrning ochledning;2016. [National Guidelines for Care in Cases of Depression and Anxiety Disorders]https:\/\/wwwsocialstyrelsense\/globalassets\/sharepoint-dokument\/artikelkatalog\/nationella-riktlinjer\/2017-12-4pdf"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12724"},{"key":"e_1_2_11_49_1","first-page":"715","article-title":"Architecture and functioning of child and adolescent mental health services: a 28\u2010country survey in Europe. Lancet","volume":"4","author":"Signorini G","year":"2017","journal-title":"Psychiatry"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12877"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1677-y"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.10.013"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Facps.13116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/acps.13116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/acps.13116","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/acps.13116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T03:36:17Z","timestamp":1721878577000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/acps.13116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1111\/acps.13116"],"URL":"https:\/\/doi.org\/10.1111\/acps.13116","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"2019-10-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}